The most widely accepted hypothesis proposes increased levels of the incretin hormone glucagon-like peptide-1 (GLP-1) leading to islet cell hyperplasia, postprandial hyperinsulinemia, and subsequent hypoglycemia [8]. The gene discussed is GCG; the disease is hyperinsulinism.